Aceto Corporation  

(Public, NASDAQ:ACET)   Watch this stock  
Find more results for ACET
16.76
-0.57 (-3.29%)
After Hours: 16.76 0.00 (0.00%)
Jul 31, 5:04PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 16.66 - 17.13
52 week 14.28 - 25.25
Open 17.13
Vol / Avg. 191,577.00/185,908.00
Mkt cap 481.51M
P/E 16.50
Div/yield 0.06/1.43
EPS 1.02
Shares 28.73M
Beta 1.50
Inst. own 71%
Aug 25, 2014
Q4 2014 Aceto Earnings Release (Estimated) Add to calendar
Jun 3, 2014
Aceto at Jefferies Global Healthcare Conference - Webcast
May 9, 2014
Q3 2014 Aceto Earnings Conference Call - Webcast
May 8, 2014
Q3 2014 Aceto Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin 4.29% 4.47%
Operating margin 5.67% 6.89%
EBITD margin - 8.28%
Return on average assets 6.23% 7.17%
Return on average equity 9.73% 12.31%
Employees 233 -
CDP Score - -

Address

4 Tri Harbor Court Port Washington
PORT WASHINGTON, NY 11050
United States - Map
+1-516-6276000 (Phone)
+1-516-6276093 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Aceto Corporation (Aceto) is primarily engaged in the sourcing, regulatory support, quality assurance, marketing, sales and distribution of pharmaceutical intermediates and active ingredients, finished dosage form generics, nutraceutical products, agricultural protection products and specialty chemicals used principally as finished products or raw materials in the pharmaceutical, nutraceutical, agricultural, coatings and industrial chemical consuming industries. The Company operates in three segments: Human Health, Pharmaceutical Ingredients and Performance Chemicals. The Company has presence in China, Germany, France, the Netherlands, Singapore, India, Hong Kong, the United Kingdom and the United States, along with warehouses worldwide. In May 2014, the Company completed the acquisition of PACK Pharmaceuticals, LLC.

Officers and directors

Albert L. Eilender Chairman of the Board
Age: 70
Bio & Compensation  - Reuters
Salvatore J. Guccione President, Chief Executive Officer, Chief Operating Officer, Director
Age: 50
Bio & Compensation  - Reuters
Douglas A. Roth Chief Financial Officer, Senior Vice President
Age: 56
Bio & Compensation  - Reuters
Satish Srinivasan President and Chief Operating Officer of Rising Pharmaceuticals
Age: 44
Bio & Compensation  - Reuters
Steven Rogers Senior Vice President, General Counsel, Corporate Secretary
Age: 52
Bio & Compensation  - Reuters
Charles J. Alaimo Senior Vice President - Human Resources
Age: 47
Bio & Compensation  - Reuters
Raymond Bartone Senior Vice President - Nutritionals
Age: 51
Bio & Compensation  - Reuters
Frank V. DeBenedittis Senior Vice President - Corporate Business Development
Age: 59
Bio & Compensation  - Reuters
Carlos Restrepo Senior Vice President - Performance Chemicals
Age: 51
Bio & Compensation  - Reuters
Nicholas I. Shackley Senior Vice President - Pharmaceutical Ingredients
Age: 49
Bio & Compensation  - Reuters